Skip to main content

Table 1 Patients’ demographic and historical variables in both groups

From: Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery

 

Group S (n = 37)

Group H (n = 35)

P

Age (years)

53.76 ± 9.73

53.63 ± 12.90

0.962

Gender (Male/female) (n)

25/12

20/15

0.361

Weight (kg)

63.64 ± 10.78

59.26 ± 12.42

0.114

Height (cm)

165.65 ± 8.24

164.17 ± 8.24

0.450

Education level

 Primary / junior /senior/ university (n)

5/22/3/7

5/19/6/5

0.683

ASA status I/II(n)

19/18

17/18

0.814

Previous history of surgery (n)

17

10

0.128

Previous history of PCA (n)

5

0

0.073

Diabetes (n)

2

1

1.000

Hypertension (n)

13

6

0.083

Smoking (n)

11

11

0.875

Motion sickness (n)

2

1

1.000

  1. Values are expressed as mean ± SD or number of patients
  2. ASA American Society of Anesthesiologists